Erratum: Expression of growth arrest-specific protein 6 and Axl molecules in the left internal mammary artery of patients undergoing coronary artery bypass grafting (Journal of Clinical Pathology (2014) 67 (506-511) DOI: 10.1136/jclinpath-2013-202000);Expression of growth arrest-specific protein 6 and Axl molecules in the left internal mammary artery of patients undergoing coronary artery bypass grafting

Journal of Clinical Pathology

Volumn 67, Issue 6, 2014, Pages 506-511

  Lee, Chien Hsing ^a   Shieh, Yi Shing ^a   Tsai, Chien Sung ^a   Hung, Yi Jen ^a   Tsai, Yi Ting ^a   Lin, Chih Yuan ^a  

^a TRI SERVICE GENERAL HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

AXL PROTEIN; GROWTH ARREST SPECIFIC PROTEIN 6; HEMOGLOBIN A1C; MESSENGER RNA; PROTEIN; UNCLASSIFIED DRUG;

AGED; AORTA; ARTICLE; ARTIFICIAL VENTILATION; CLINICAL ARTICLE; CORONARY ARTERY BYPASS GRAFT; ELECTIVE SURGERY; FEMALE; HEART INFARCTION; HEART LEFT VENTRICLE EJECTION FRACTION; HEMOGLOBIN BLOOD LEVEL; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; INTERNAL MAMMARY ARTERY; MALE; PERIOPERATIVE PERIOD; PEROPERATIVE COMPLICATION; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; SURGICAL INFECTION; WESTERN BLOTTING;

ATHEROSCLEROSIS; CARDIOVASCULAR; VASCULAR DISEASE;

AGED; AORTA; BLOTTING, WESTERN; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; INTERNAL MAMMARY-CORONARY ARTERY ANASTOMOSIS; MALE; MAMMARY ARTERIES; MIDDLE AGED; PROTO-ONCOGENE PROTEINS; REAL-TIME POLYMERASE CHAIN REACTION; RECEPTOR PROTEIN-TYROSINE KINASES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SURGICAL PROCEDURES, ELECTIVE;

EID: 84901648674     PISSN: 00219746     EISSN: 14724146     Source Type: Journal    
DOI: 10.1136/jclinpath-2013-202000corr1     Document Type: Erratum

References (35)

1. Iaco AL, Teodori G, Di Giammarco G, et al. Radial artery for myocardial revascularization: long-term clinical and angiographic results. Ann Thorac Surg 2001;72:464-8. (Pubitemid 32727148)
2. He GW. Arterial grafts for coronary surgery:vasospasm and patency rate. J Thorac Cardiovasc Surg 2001;121:431-3.
3. Barry M, Touati G, Chardon K, et al. Histologic study of coronary, radial, ulnar, epigastric and internal thoracic arteries: application to coronary artery bypass grafts. Surg Radiol Anat 2007;29:297-302. (Pubitemid 46863738)
4. He GW. Arterial grafts for coronary artery bypass grafting: biological characteristics, functional classification, and clinical choice. Ann Thorac Surg 1999;67:277-84.
5. Schneider C, King RM, Philipson L. Genes specifically expressed at growth arrest of mammalian cells. Cell 1988;54:787-93.
6. Stitt TN, Conn G, Gore M, et al. The anticoagulation factor protein S and its relative, Gas6, are ligands for the Tyro 3/Axl family of receptor tyrosine kinases. Cell 1995;80:661-70.
7. Fernandez-Fernandez L, Bellido-Martin L, Garcia de Frutos P. Growth arrest-specific gene s (GAS6). An outline of its role in haemostasis and inflammation. Thromb Haemost 2008;100:604-10.
8. Hafizi S, Dahlback B. Gas6 and protein S: vitamin K-dependent ligands for the Axl receptor tyrosine kinase subfamily. FEBS J 2006;273:5231-44. (Pubitemid 44772384)
9. Nakano T, Higashino K, Kikuchi N, et al. Vascular smooth muscle cell-derived, GIa-containing growth-potentiating factor for Ca(2+)-mobilizing growth factors. J Biol Chem 1995;170:5702-5705.
10. Tjwa M, Bellido-Martin L, Lin Y, et al. Gas6 promotes inflammation by enhancing interactions between endothelial cells, platelets, and leukocytes. Blood 2008;111:4096-105.
11. Korshunov VA, Mohan AM, Georger MA, et al. Axl, a receptor tyrosine kinase, mediates flow-induced vascular remodeling. Circ Res 2006;98:1446-52. (Pubitemid 43948070)
12. Melaragno MG, Wuthrich DA, Poppa V, et al. Increased expression of Axl tyrosine kinase after vascular injury and regulation by G protein-coupled receptor agonists in rats. Circ Res 1998;83:697-704. (Pubitemid 28462783)
13. Korshunov VA, Ber K BC. Smooth muscle apoptosis and vascular remodeling. Curr Opin Hematol 2008;15:250-4. (Pubitemid 351507578)
14. Cavet ME, Smolock EM, Ozturk OH, et al. Gas6-axl receptor signaling is regulated by glucose in vascular smooth muscle cells. Arterioscler Thromb Vasc Biol 2008;28:886-91. (Pubitemid 351544103)
15. Korshunov VA, Daul M, Massett MP, et al. Axl mediates vascular remodeling induced by deoxycorticosterone acetate-salt hypertension. Hypertension 2007;50:1057-62. (Pubitemid 350172927)
16. D'Arcangelo D, Gaetano C, Capogrossi MC. Acidification prevents endothelial cell apoptosis by Axl activation. Circ Res 2002;91:e4-12.
17. Clauser S, Meilhac O, Bieche I, et al. Increased secretion of Gas6 by smooth muscle cells in human atherosclerotic carotid plaques. Thromb Haemost 2012;107:140-9.
18. Alciato S, Sainaghi PP, Sola D, et al. TNF-alpha, IL-6, and IL-1 expression is inhibited by GAS6 in monocytes/macrophages. J Leukoc Biol 2010;87:869-75.
19. Avanzi GC, Gallicchio M, Bottarel F, et al. GAS6 inhibits granulocyte adhesion to endothelial cells. Blood 1998;91:2334-40. (Pubitemid 28155506)
20. Son BK, Kozaki K, Iijima K, et al. Statins protect human aortic smooth muscle cells from inorganic phosphate-induced calcification by restoring Gas6-Axl survival pathway. Circ Res 2006;98:1024-31.
21. Ekman C, Site DF, Gottsater A, et al. Plasma concentrations of growth arrest specific protein 6 and the soluble form of its tyrosine kinase receptor Axl as markers of large abdominal aortic aneurysms. Clin Biochem 2010;43:110-14.
22. Ekman C, Gottsater A, Lindblad B, et al. Plasma concentrations of Gas6 and soluble Axl correlate with disease and predict mortality in patients with critical limb ischemia. Clin Biochem 2010;43:873-6.
23. Hung YJ, Lee CH, Chu NF, et al. Plasma protein growth arrest-specific 6 levels are associated with altered glucose tolerance, inflammation, and endothelial dysfunction. Diabetes Care 2010;33:1840-4.
24. He GW, Yang CQ. Comparison among arterial grafts and coronary artery. An attempt at functional classification. J Thorac Cardiovasc Surg 1995;109:707-15.
25. Khot UN, Friedman DT, Pettersson G, et al. Radial artery bypass grafts have an increased occurrence of angiographically severe stenosis and occlusion compared with left internal mammary arteries and saphenous vein grafts. Circulation 2004;109:2086-91. (Pubitemid 38620216)
26. Mussa S, Choudhary B, Taggart D. Radial artery conduits for coronary artery bypass grafting: current perspective. J Thorac Cardiovasc Surg 2005;129:250-3.
27. Sisto T. Atherosclerosis in internal mammary and related arteries. Scand J Thorac Cardiovasc Surg 1998;24:7-11.
28. Weiss SJ. Tissue destruction by neutrophils. N Engl J Med 1989;320:365-77.
29. Toothill VJ, Van Mourik JA, Niewenhuis HK, et al. Characterization of enhanced adhesion of neutrophil leukocytes to thrombin-stimulated endothelial cells. J Immunol 1990;145:283-91. (Pubitemid 20217413)
30. Fridell YW, Villa J Jr., Attar EC, et al. GAS6 induces Axl-mediated chemotaxis of vascular smooth muscle cells. J Biol Chem 1993;273:7123-6.
31. Melaragno MG, Cavet ME, Yan C, et al. Gas6 inhibits apoptosis in vascular smooth muscle: role of Axl kinase and Akt. J Mol Cell Cardiol 2004;37:881-7. (Pubitemid 39222079)
32. Melaragno MG, Fridell YW, Berk BC. The Gas6/Axl system: a novel regulator of vascular cell function. Trends Cardiovasc Med 1999;9:250-3.
33. Gibot S, Massin F, Cravoisy A, et al. Growth arrest-specific protein 6 plasma concentrations during septic shock. Crit Care 2007;11:R8.
34. Burnier L, Borgel D, Angelillo-Scherrer A, et al. Plasma levels of the growth arrest-specific gene 6 product (Gas6) and antiplatelet drug responsiveness in healthy subjects. J Thromb Haemost 2006;4:2283-4. (Pubitemid 44400314)
35. Muñoz X, Obach V, Hurtado B, et al. Association of specific haplotypes of GAS6 gene with stroke. Thromb Haemost 2007;98:406-12. (Pubitemid 47250244)